1) Medical Diagnostics
Abstract
Investigate medical diagnostics ubiquitous and comprehensive against chemical and biological threats (including NTAs, pharmaceutical-based agents, and toxins) by advancing diagnostic innovations; investigating emerging technologies; ensuring medical diagnostics rapid adaptation to emerging threats; harvesting and synergizing the immense volume of diagnostic data; and aligning medical diagnostics capabilities with the FDA pipeline and larger commercial supply chain.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2021
- Source ID
- 211e1f208d13d65b7b42a1a39d7d9ab7